Abstract:Background: Declined estimated kidney function has been shown to be independently associated with a higher risk of cardiovascular disease (CVD), although on the population level the evidence for causality is limited. We aimed to compare the observational associations of various estimated kidney function measurements with CVD and its subtypes, and further assessed the potential causality utilizing Mendelian randomization (MR) analyses.Methods: Six measurements were used to estimate kidney function, including circulating levels of cystatin C and creatinine, urine albumin-to-creatinine ratio (uACR), and estimated glomerular filtration rates (eGFRs) from three CKD-EPI formulae (i.e., that using cystatin C[eGFRcys], creatinine[eGFRcre], and both[eGFRcys+cre]).Results: Among 324,982 participants from UK Biobank who were followed up for over 2.55 million person-years, per standard deviation increase in baseline levels of log cystatin C (hazard ratio, 1.14; 95% confidence interval, 1.13-1.16), log creatinine (1.05 [1.03-1.07]) or log uACR (1.04 [1.03-1.06]), and per standard deviation decrease in baseline eGFR estimates based on the 3 formulae (e.g., of eGFRcys+cre, 0.88 [0.87-0.90]) was associated with a higher risk of CVD. In contrast, two-sample MR analyses did not suggest significant associations of any genetically instrumented kidney function measurement with the risk of CVD (e.g., the odds ratio of eGFRcys+cre, 0.97; 95% confidence interval, 0.92-1.02) or its subtypes, including coronary artery disease and ischemic stroke.Conclusions: This study confirmed significant associations of kidney function measurements in clinical practice with CVD risk. However, Mendelian randomization analyses did not support the causality of such associations.Funding Information: This work was supported by the National Key R&D Program of China (2020YFC2005000) and the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning.Declaration of Interests: The authors declare no conflict of interest.Ethics Approval Statement: The UK Biobank study was approved by the North West Multi-Centre Research Ethics Committee. Written consents were obtained from all participants in the UK Biobank. Informed consent was obtained from each participant, and the study was approved by the North West Multicentre Research Ethics Service Committee.

Kidney Function and Cardiovascular Disease: an Observational and Mendelian Randomization Study